Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
EPS HEALTH TECH Terminates Acquisition of Stake in China Genetic
Recommend 2 Positive 1 Negative 0 |
||||
|
||||
|
EPS HEALTH TECH (03860.HK) announced that in relation to its proposed acquisition of a 16.23% stake in China Genetic Limited from Honestar Medical Limited, the parties to the Agreement agreed to mutually terminate the Acquisition with no liability and further obligation on either party. The Board considers that the termination of the Agreement has no material adverse effect on the business and operation of the Group. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
